Novavax (NVAX) Gross Margin Growth (1y) (2012 - 2026)
Novavax (NVAX) Gross Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -93.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -91.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 236.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 228.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 6.06 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -475.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1,034.00 |
| 10 | Novavax | 1.33 Bn | 607.37 Mn | 42.45 Mn | -1,872.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,872.00 |
| Mar 31, 2026 | -1,988.00 |
| Dec 31, 2025 | 2,650.00 |
| Sep 30, 2025 | 4,121.00 |
| Jun 30, 2025 | 237.00 |
| Mar 31, 2025 | 6,097.00 |
| Dec 31, 2024 | 1,167.00 |
| Sep 30, 2024 | -1,882.00 |
| Jun 30, 2024 | 201.00 |
| Mar 31, 2024 | -2,098.00 |
| Dec 31, 2023 | -234.00 |
| Sep 30, 2023 | 626.00 |
| Jun 30, 2023 | 13,266.00 |
| Mar 31, 2023 | -3,995.00 |
| Dec 31, 2022 | -5,086.00 |
| Sep 30, 2022 | -5,916.00 |
| Jun 30, 2022 | -14,580.00 |
| Mar 31, 2022 | -216.00 |
| Sep 30, 2015 | 693.00 |
| Jun 30, 2015 | 4,258.00 |